Skip to main content
. 2024 Apr 8;25(7):4117. doi: 10.3390/ijms25074117

Table 1.

Clinicopathologic characteristics by M2TS expression levels.

M2TS Expression p-Value
Low
n = 15 (%)
High
n = 13 (%)
Age (years) ≤40 6 (40.0) 1 (7.7) 0.086
>40 and ≤65 4 (26.7) 8 (61.5)
>65 5 (33.3) 4 (30.8)
Age (years) Mean ± SD 51.7 ± 20.2 60.7 ± 13.6 0.184
Gender Female 9 (60.0) 4 (33.3) 0.322
Male 6 (40.0) 8 (66.7)
Ethnicity Asian 5 (33.3) 4 (30.8) 0.288
Black 1 (6.7) 0 (0.0)
Hispanic 6 (40.0) 3 (23.1)
Non-Hispanic White 2 (13.3) 6 (46.2)
Other 1 (6.7) 0 (0.0)
Cytology Negative 6 (40.0) 4 (30.8) 0.91
Positive 9 (60.0) 9 (69.2)
Lauren Classification Diffuse 11 (73.3) 10 (76.9) 1.0
Intestinal 4 (26.7) 3 (23.1)
Differentiation Moderately 0 (0.0) 2 (15.4) 0.144
Poorly 15 (100.0) 10 (76.9)
Well to moderately 0 (0.0) 1 (7.7)
Signet Ring Cell Absent 5 (33.3) 8 (61.5) 0.266
Present 10 (66.7) 5 (38.5)
Microsatellite Status MSI high 1 (6.7) 0 (0.0) 0.55
MSS 12 (80.0) 12 (92.3)
Unknown 2 (13.3) 1 (7.7)
PD-L1 Negative 4 (26.7) 5 (38.5) 0.52
Positive 10 (66.7) 6 (46.2)
Unknown 1 (6.7) 2 (15.4)
Stage I–III 2 (13.3) 2 (15.4) 1.0
IV 13 (86.7) 11 (84.6)
Serum Albumin <3 g/dL 4 (26.7) 5 (38.5) 0.794
≥3 g/dL 11 (73.3) 8 (61.5)

M2TS, M2 transcriptomic signature. SD, standard deviation. MSI, microsatellite instable. MSS, microsatellite stable.